Comparison of extended intervals and dose reduction of omalizumab for asthma control

ConclusionIf patients or physicians wish to reduce the cumulative dose of omalizumab after achieving good asthma control, extension of the interval between doses appears to be a  better approach than dose reduction.
Source: Allergo Journal International - Category: Allergy & Immunology Source Type: research